The aims of this study are to determine the frequency of diagnosis of atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) at stereotaxic-guided ll-gauge vacuum-assisted breast biopsy (VABB) and to assess the rate of underestimation of these at subsequent surgical excision and follow-up. Moreover, we aimed to define clinical, radiological and histological features of nonpalpable lesions in core biopsies that predict the lesion upgrade. Retrospective review of ll-gauge VABB was performed to identify the underestimation rate of nonpalpable lesions diagnosed as ALH or LCIS at VABB. Thirteen cases of ALH and 36 cases of LCIS were sent to surgery, 29 cases of ALH and 14 cases of LCIS were sent to follow-up. The clinical, mammographic and histologic features were assessed. The correlation between mammographic BI-RADS score and histological B-c1assification for both ALH and LCIS lesions were performed by Pearson's test. Of 1,765 patients enrolled, lobular lesions (ALH and! or LCIS) occurred in 82 cases, and underestimation arose in 9 (10.9%). Two cases of underestimated ALH were upgraded to invasive lobular carcinoma and one to invasive ductal carcinoma. One case of underestimated LCIS was upgraded to ductal carcinoma in situ, two to invasive ductal carcinoma and three to invasive lobular carcinoma. The histology of the core and surgical specimens were compared. A significant difference was seen in the BI-RADS score (4-5 in 91% of underestimated lesions), and the size of the lesions (2: 1.5 em) for underestimated cases versus accurately diagnosed cases (p<O.OOI). Further significant parameters predictive for malignancy were the incomplete lesion removal by VABB and the presence of associated different breast lesions in the specimen. In conclusion, as far as ALH is concerned, we propose surgery as first choice when at least one of the following condition is respected: positive history for breast carcinoma, lesion>1.5cm, co-presence of high-risk lesions in the sample, signs of ductal involvement, high histological grading for atypia and follow-up in the other cases. Surgery is recommended in all cases of LCIS:
classification for these lesions, and the best course of long-term management after diagnosis, are far from infrequent, hypothesizing a different diagnosticprognostic approach to these kind of lesions.
Moreover, the management of lobular carcinoma in situ or atypical lobular hyperplasia diagnosed on core biopsy are not established, even though it represents the first necessary step in breast lesion characterization. The VABB technique is now increasingly used because it provides a minimally invasive, faster and less expensive method for sampling non-palpable abnormalities seen on mammograms but not visualized on sonograms. The VABB method, using II-gauge probes, can obtain core samples that are substantially larger than those obtained with the I4-gauge needle and automatic gun (2) . Previous studies have shown an upgrade to ductal carcinoma in situ or invasive carcinoma in 2% to over 40% of cases on subsequent excision of lobular neoplasia on core biopsy (3) . Few data address the frequency of ALH underestimation at VABB. This study was undertaken to determine the frequency of diagnosis of ALH and LCIS at VABB and to assess the underestimation rate of these two breast lesions. Moreover, we analyzed several clinical, radiological, and histological parameters in order to identify the most significative predictive features of lesion upgrade.
MATERIALS AND METHODS
Between November 1999 and January 2008, 1,776 stereotaxic core needle biopsies in 1,765 patients (range 32-76 years) were performed with an l l-gauge VABB device (Ethicon Endo-Surgery MAMMOTOME® Breast Biopsy System, Norderstedt, Germany). All procedures were carried out, after informed consent, on a Fisher dedicated prone table. All radiologists had prior experience in percutaneous biopsies under stereotactic and sonographic guidance. The technique of performing these biopsies has been described elsewhere (4) . The average number of core specimens obtained per case was 11 (range [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Specimen radiography was performed for all cases of calcifications.
Because there is no protocol for treatment of the patients with ALH and LCIS, treatment varies. In patients with a microhistological diagnosis of ALH, the decision to perform surgery was based on the presence of at least two of the following parameters: age <70 years; presence of familial or personal history of breast cancer; mammographic extension of the lesion~1.5 em; incomplete excision of the lesion by VABB, a parameter confirmed by postprocedural radiography; BIRADS 4-5.
-copresence of high-risk lesions (atypical ductal hyperplasia, radial scar, papillomatosis)
In the other cases we proposed a long-term followup to the patients. All patients with a microhistological diagnosis of LCIS were sent for surgery, but patients with at least two of the following parameters were sent to follow-up: age >70years; mammographic extension of the lesion <1ern; complete excision of lesions by VABB, a parameter confirmed by postprocedural radiography; absence of synchronous mass lesion.
The range of the follow-up period was between 6 months and 8 years (average 22 months). In patients referred for follow-up care regardless offamily or personal history of breast cancer, lesions had radiologically benign appearance (0.4-0.6 em, completely removed by VABB, and assessed as BI-RADS category 3).
Patients with a pathologic diagnosis of necrotizing or pleomorphic LCIS variant to the breast biopsy histology were excluded from our study (5) .
Pathology slides ofVABB and surgery were reviewed. Underestimated cancer cases were those in which either carcinoma was not diagnosed at VABB (i.e., only ALH was found) or invasive disease was not diagnosed at VABB (i.e., only LCIS was found). Classic LCIS was defined as a uniform population of small discohesive cells with bland nuclei with mild to absent pleomorphism. The threshold for the distinction of LCIS vs ALH is involvement of at least 75% of the units ofa lobule. ALH was identified by the same neoplastic cells as described for LCIS replacing the normal glandular epithelium in acinar units and effacing the lumens. The acini are small, and non-distended, and the borders of acinar units remain indistinct. An E-cadherin immunostain was performed on excisional specimens with an equivocal diagnosis on review.
All core and surgical specimens were interpreted by a single pathologist experienced in breast pathology. VABB tissue cores were placed in cassettes, up to three cores per cassette for routine tissue processing (6) Excisional biopsy specimens were oriented by the surgeon and the margins were inked by the pathologist. For mastectomy specimens the following were routinely sampled: biopsy site, nipple and skin, deep margin, and two random sections per quadrant (6) . All tissue samples were routinely fixed in 4% neutral buffered formalin and embedded in paraffin. Histological assessment was performed on 5 micron-thick Hand E-stained sections; three level sections were examined from each cassette of the VABB tissue cores and one level section from each cassette of the surgical specimens (excision, mastectomy). Two separate analyses were performed to compare the accurately diagnosed and underestimated cases.
We accurately compared diagnosis vs underestimated ALH and LCIS group sent to surgery and accurate diagnosis vs underestimated in ALH and LCIS group sent to follow-up. The underestimated and the accurately diagnosed cases were compared in terms of patient age, occurrence of familial and personal risk factors (like a mutation in the BRCAI or BRCA2 gene, or a firstdegree relative with a mutation; a strong family history of breast cancer; a personal history of breast cancer; past radiation treatment to the chest); all patients with two or more cases of first degree relatives with history of breast cancer, underwent BRCA gene study. We also compared size (measured on the longest mammographic diameter), mammographic features (mass, calcifications, or architectural distortion), BIRADS score, B-classification for breast biopsy histology (7) and co-presence of other breast lesions, by two-ways t-test, and Yates' chi-square. The Risk Ratio and the Interval of Confidence for lesions with a longest mammographic diameter of more than 2 em for ALH, or than I em for LCIS, was estimated (8) . The correlation between mammographic BI-RADS score and histological B-classification for both ALH and LCIS lesions was performed by Pearson's test. A retrospective review ofthe specimen radiographs and the mammograms obtained before biopsy was performed to estimate the proportion of calcifications per lesion retrieved during VABB.
Specimen mammography was carried out to identify microcalcifications in cases with microcalcifications detected in mammogram, and rate of retrieval was considered low ifless than 25%, moderate if25-75%, and high if greater than 75% of the calcifications constituting the lesion were removed (9) . All data collection was performed in a blind manner: the observer making the measurements was not aware of the lesion (ALH or LCIS) or the treatment (surgery or follow-up) to which each group was subjected. Data from all the quantitative analyses were analyzed by SigmaStat 3.5 software integration (SPSS, Erkrath, Germany). Statistical significance was indicated by ap value equal to or less than 0.05.
RESULTS
Ninety-eight cases of ALH or LCIS were diagnosed. Sixteen cases of 16 patients with a pathological diagnosis ofnecrotizing or pleomorphic LCIS were excluded by our study for their higher malignancy rate that requires a different therapeutic management.
The 82 lesions yielding ALH or LCIS at VABB occurred in 82 women having a median age of 53 years (range, 30-75 years). Of the 82 reviewed lesions, 31 (38%) occurred in premenopausal women and 51 (62%) in postmenopausal women.
Mammographic lesion type was characterized by microcalcifications in 60 (73%) cases, mass in 12 (15%) cases, and parenchymal distortion in 10 (12%) cases. Ten patients with the finding of mass (n=6) or parenchymal distortion (n=4) had previously undergone fine needle aspiration cytology (FNAB) that resulted insufficient (C1) or uncertain (C3). 81-RADS score was 4-5 in 59 (72%) cases, and 3 in the others (28 %). Median lesion size was 1.3 em (range, 0.3--4.0 em). Median number of biopsy specimens obtained was 11 (range 8-18) (Table I) .
Histological B-classification resulted B3 in 32 cases (39%), B4 in 26 (31.7%), and B5 in the other 24 cases (29.3%). There was a significant and positive correlation between radiological (BIRADS) and pathological score for all lesions (r = 0.77; P < 0.001).
Among the 82 cases with mammographic- Retrospective review to identify cases of ALH or LCIS found at VABB yielded 82 cases, of which 42 (51.2%) were ALH and 40 (48.8%) were LCIS. These patients were then ranked into two groups: one group was sent to surgery of which 13 ALH and 36 LCIS, and the other was sent to follow-up (after six months by VABB, and if negative for lesion evolution, annually) of which 29 ALH and 4 LCIS.
Of the 49 cases sent to surgery (13 ALH and 36 LCIS), 9 cases (10.9%) were underestimated: 3 cases ofALH were upgraded to invasive lobular carcinoma (2 cases) and to invasive ductal carcinoma (1 case); 6 cases of LCIS were upgraded to ductal carcinoma in situ (1 case), invasive ductal carcinoma (2 cases) and invasive lobular carcinoma (3 cases).
Of 36 cases sent to follow-up (29 ALH and 4 LCIS), no lesion evolved. In these cases, the underestimation rate is 0% (Table II) .
ALH (n=42)
Regarding the ALH cases that underwent surgery (n=13), the patients mean age was 55 years with a positive familial and personal history for risk factors in 4 (31%) and 8 (61%) cases, respectively. The BI-RADS score was 3 in two patients (15%) and 4-5 in the others (11 patients, 85%). The mean diameter of lesions was 1.6 em (range, 0.4 -3.5 em), with a complete lesion retrieval by VABB in 2 patients (15%). In all cases (100%) VABB revealed lesion ductal involvement (5 samples) and/or high-risk lesions linked, such as atypical ductal hyperplasia, radial scar, papillomatosis (9 samples). The histological B-score was B3 in two patients, and B4 in II samples, with no cases scored as B5 at breast biopsy histology. Among thirteen lesions yielding ALH at VABB and sent to surgery, surgical excision revealed invasive cancer in three (23% of underestimation at VABB) cases (Fig. I) .
Histological subtype was invasive lobular carcinoma in 2 cases, and invasive ductal carcinoma in the other one.
The likelihood of ALH underestimation was significantly higher in patients with a posinve familial history of cancer (3/3 cases, 100% of underestimated lesions) (p=0.02). All (3/3) underestimated ALH cases were reported as "markedly atypical". A BI-RADS score of 4-5 was detected in 3/3 cases (100% of underestimated lesions). A suspected B-score of B4 was assigned for all the underestimated lesions. No lesion with a diameter less than 1.5 em was underestimated. The Risk Ratio of VABB underestimation for ALH lesions with a mammographic diameter longer than 2 cm demonstrated a positive association between lesion size and possibility of VABB misdiagnosis (Relative risk R: 6.5; rc 95%: 1.9-22.1). A further significant parameter linked to the rate of VABB underestimation was the co-presence of other highrisk lesions (3/3 cases, 100% of underestimated lesions) (p=0.003), and in particular for the finding of radial scar in one case, ductal involvement in another and ADH in a third. Moreover, only one lesion was completely retrieved at VABB (33.3% of retrieval). Finally a histological high grading for atypia was shown to be significantly linked to a major risk of malignancy (100% of underestimated lesions) (Table   III ).
In the ALH cases which were followed-up (n=29), the patients mean age was 57 years with a positive familial and personal history for risk factors in 2 (7%) and 2 (7%) cases, respectively. The BI-RADS score was 4-5 in fourteen patients (48%). The mean lesion size was 0.8 em (range, 0.4-1.8 em), with a complete lesion retrieval by VABB in 20 patients (69%) . The bioptic histological analysis confirmed ALH. The histological B-score was B3 in twentynine patients, with no samples scored as B4 or B5 at breast biopsy histology. The check-up at two and five years did not reveal any lesion progression. There was a significant and positive correlation between radiological and pathological score for ALH lesions (r = 0.5; p < 0.001) .
LCIS (n=40)
As far as the LCIS cases that underwent surgery (n=36), the patients mean age was 59 years with a positive familial and personal history for risk factors in 4 (II %) and 6 (17%) cases , respectively. The BI-RADS score was 3 in five patients (14%) and 4-5 in the other ones (31 patients, 86%). The mean diameter of lesions was 1.8 em (range, o .~ern), with a complete lesion retrieval by VABB in 10 
. Patient with LClS diagnosis by VABB and invasive lobular carcinoma following surgical excision. In (A) and (B), respectively. the cranial-caudal and oblique projection ofmammography shows a cluster ofmicrocalcifications without a clear mass in the deep superior-lateral right region (BIRADS 4-5). C) Partial retrieval achieved by II gaug e VABB (moderate retrieval). more evident at 9 and 10position. D. E) Histology on biopsy sample demonstrats l.CiS. F) Histology on surgical sample demonstrats an invasive lobular carcinoma (Hematoxyline and Eosin staining, 100x magnification).
patients (28%). In 8 cases (20%) VABB revealed lesion ductal involvement (3 samples) and/or highrisk lesions linked (7 samples). The histological B-score was B4 in 12 patients , and B5 in the other ones (24 samples).
Among thirty-six lesions yielding LCIS at VABB and sent for surgery, surgical excision revealed cancer in six (17% of underestimation at VABB) ( Fig. 2) . Histological subtype was ductal carcinoma in situ in I case, invasive ductal carcinoma in two patients, and invasive lobular carcinoma in the remainder. Four of six underestimated LCIS cases were reported as "possible invasion".
The likelihood of LCIS underestimation was significantly higher in patients with a positive familial history for cancers (4/6 cases, 67% of underestimated lesions) (p=0.00005). A BI-RADS score of 4-5 was detected in 5/6 cases (83% of underestimated lesions) . A B-score of B4 and B5 was assigned respectively in I and 5 underestimated lesions . No lesion with a diameter less than 0.5 em was underestimated, and the average diameter of misdiagnosed lesions was 2.1 cm. The Risk Ratio of VABB underestimation for LCIS lesions with mammographic diameter longer than I cm demonstrated a positive association between lesion size increase and rate of misdiagnosis (Relative risk R: 1.9; rc 95%: I. I-3.2). Another significant parameter linked to the rate ofVABB underestimation was the co-presence of other high-risk lesions (5/6 cases, 83% of underestimated lesions) (p=0 .0007). In particular, histological analysis showed radial scar in one patient, ductal involvement in two cases , ductal involvement and necrosis in another one , and ADH in yet another. The only accurately diagno sed case showing a high-risk lesions (i.e., papilloma) had benign-like radiological features with a BI-RADS score of 3 and a lesion size of 0.7 cm. Moreover, a complete lesion retrieval at VABB was reached only in I underestimated lesion (17%).
In the LeIS cases that were followed-up (n=4), the patients' mean age was 57 years, with a negative familial and personal history for risk factors in all cases. In two cases the patients were over seventy years of age, with a lesion smaller than I ern, in the other cases mammography detected a microcalcification cluster of 0.3-0.4 ern classified as BI-RADS 3 and completely removed by VABB (high calcification retrieval). In all cases the bioptic histological analysis revealed a "pure LCIS" without ductal involvement or linked high-risk lesions. The histological B-score was B4 in all patients (4 cases).
The check-up at two and five years did not reveal any lesion progression. There was a significant and positive correlation between radiological and pathological score for LCIS lesions (r = 0.88; P < 0.001).
DISCUSSION
The term of LN is often used to depict a wide range of breast parenchymal abnormalities including ALH and LCIS. The distinction between ALH and LCIS is usually based on the degree of involvement of acini in the terminal ductal lobular unit (10, 11) .
Underestimation occurs mainly because tissue sampling does not include the entire lesion. It reflects the biological nature of some lesions. Moreover, mistakes could rise up when ALH/LCIS is superimposed on other kinds of breast lesions. The result is ALH/LCIS underestimation, which occurs when either carcinoma was not diagnosed at stereotaxic core needle biopsy (i.e., only atypical lobular hyperplasia was found by VABB) or invasive disease was not diagnosed at stereotactic core needle biopsy (i.e., only lobular carcinoma in situ was found by VABB). Reported malignancy underestimation rates range from 0 to 50% and, in more recent studies, up to 58.3% (3; 12) (Table IV) (13) (14) (15) (16) (17) (18) (19) (20) .
The underestimation rate in our study was 10.9%, although it would be much lower if we consider that 3/3 cases of ALH showed "marked atypical ALH" and "LCIS with possible invasion".
There are several reasons to explain the falsenegative core-needle biopsy rate for ALH or LCIS: some are technical, as in the failure to adequately target the lesion; some are interpretive, as in the misdiagnosis of low-grade solid ductal carcinoma in situ and LCIS; and some are biological, as would occur if a population of LCIS lesions were truly premalignant. Some of these false-negative coreneedle biopsy results may be prospectively avoided with assiduous attention to biopsy technique and pathologic analysis of the core specimens. (19) When specified, needle gauges ranged from 8 to 14, and both automated needle devices and vacuumassisted probes were used. When specified, numbers of cores per lesion ranged from 3 to 43. Upgrades were noted with all needle gauges and biopsy devices. There were several upgrades reported with vacuum-assisted Il-G probes and more than 10 cores of tissue, but with a vacuum-assisted 8 gauge probe (providing larger, less fragmented and less hematic specimens for histological evaluation), and 11-17 probes are associated to higher diagnostic accuracy and lower risk of underestimation (12, 19) Although many studies focused their attention on atypical ductal hyperplasia or ductal carcinoma in situ underestimation at VABB (6; 21-23), very few authors examined the efficacy of this technique in the characterization of ALH and LCIS lesions (24) . Therefore, standardized recommendations for the management of lobular carcinoma in situ or atypical lobular hyperplasia diagnosed on core biopsy have not been established because of disagreement (10) . In our study, we found that among lesions yielding pure ALH at VABB, subsequent surgery revealed cancer in 23%, whereas among lesions yielding pure LCIS at VABB, surgery revealed invasive carcinoma in 17%. The more frequent histological subtype detected was invasive lobular carcinoma (67% and 50% of underestimated cases of ALH and LCIS respectively), followed by invasive ductal carcinoma (33% of underestimated cases of ALH and LCIS), and ductal carcinoma in situ (17% of underestimated cases ofLCIS). These results are in accordance with a number of studies which have shown DCIS and invasive carcinoma following excision of lesions yielding ALH and LCIS at percutaneous biopsy (10, 24, 25) . The risk appears to be lowest for ALH and highest for pleomorphic LCIS with central necrosis and in lesions in which residual calcifications remain in situ. None of the patients sent to follow-up for ALH or LCIS suffered a progression oflesion.
In our study the underestimation rate seems to increase for cases of ALH with a lesion size bigger than 1.5 cm, and of LCIS with a diameter bigger than 0.5 em, as shown by the Risk Ratio of VABB underestimation for patients sent to surgery or follow-up, accordingly to the kind of lesion. This data is very interesting considering that others studies (8) identified, at MRI-guided 9-gauge VABB, a diameter cut-off of 6 em to encompass 60% of underestimated lesions for lesions yielding ductal carcinoma in situ. Recently, several authors (26) analyzed the incidence of malignancy in patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast lesions and found a significant underestimation of malignancy in patients with this kind of lesion. Moreover, other works (27) (28) (29) (30) emphasize the heterogeneity of B3 lesions and the likelihood of malignancy for these lesions, underlining new patient pathways for their management.
Interestingly,BI-RADS score resulted predictive for suspected lesion being 4-5 in 100% of lesions yielding ALH at VABB and in 83% oflesions yielding LCIS at VABB. These data are in accordance with other studies (21, (31) (32) (33) that assessed the efficacy of BI-RADS score in the stratification ofrisk breast lesions, showing a correlation among BI-RADS category and diagnosis of breast cancer (category 3 = 4%; category 4 = 15%; and category 5 = 79%). A correlation was also found for "not pure" ALHILCIS lesions. The likelihood of underestimation was 100% for ALH and 83% for LC1S. The only accurately diagnosed LCIS case with a linked high-risk lesion showed "benign" parameters for BI-RADS score or lesion size.
The other parameter identified as predictive for lesion malignancy was lesion retrieval at VABB. In our study we completely removed only 47% and 69% ofALH sent to surgery and to follow-up, respectively. As for as underestimated LCIS lesions, a complete retrieval was reached in 17% and 50% of cases sent to surgery and to follow-up, respectively. Therefore, a major retrieval was obtained for the cases sent to follow-up and did not evolve over time. As in other studies (21) , no underestimations were found among cases in which the entire mammographic lesion was removed at VABB.
In summary, surgery revealed invasive cancer in 23% of lesions for which VABB yielded "pure" ALH (3/13) and in 17% oflesions for which VABB yielded "pure" LCIS (6/36).
All women diagnosed with lobular carcinoma in situ, atypical lobular hyperplasia or lobular neoplasia are at an increased risk of developing breast cancer in both the ipsilateral and contralateral breast (13) (14) (15) .
Some investigators point to the fact that because the risk of developing breast cancer involves all breast tissue, surgical excision of one region is not indicated and mammographic follow-up is more appropriate (20) . Londero and Foster recommend surgical excision in case of percutaneous lobular neoplasia diagnosis because of its role as a precursor of breast cancer and because of the known risk of underestimation (12, 18) . Mahoney recommend that excisional surgical biopsy be performed in cases of lobular neoplasia diagnosed at stereotactic core needle biopsy to exclude a coexistent intraductal or invasive carcinoma that may be present in 19% of these patients (20) .
Liberman recommend eXClSIOn when the percutaneous biopsy histological features overlapped with those of DCIS, when a high-risk lesion was present, or when there was imaging-histological discordance (34) . Berg recommend excisional biopsy only in the presence of residual microcalcifications, but ifno residual lesion is depicted at mammography, or in case of fibroadenomas with internal or adjacent lobular neoplasia, close mammographic surveillance may be reasonable (13) . Middleton recommend biannual surveillance and chemopreventive agents when lobular carcinoma in situ was diagnosed by core needle biopsy for calcifications and without an associated mass lesion or area of architectural distortion (I5).
Although number of cases reviewed is small, we could track general criteria for the management of patients with ALH or LCIS at VABB because our report represents the largest single institution series and the largest series of cases carried out exclusively with an I I-gauge VABB device with one of the least scores of underestimation.
However, in our study the absolute validity of our results was affected by no patients being enrolled over time, the small number of cases sent to folIowup, the restricted period of the follow-up, and the absence ofsurgical correlation in all cases. Moreover, conclusions on only 13 excised ALH lesions seem inconsistent although the results achieved following surgery and 5-year follow-up are significant. Another limitation of our study is represented by the data that few "pure" lesions were observed, and it is not possible to know how correctly to attribute upgrade to the ALH or LCIS. These findings are in accordance with previous studies (24) that demonstrated the frequent association of LN with other "high risk lesions" and that recommend surgical excision only in case of previous or present history of breast neoplasm, LN associated with another "high risk lesion", histologic features of DCIS or radiologicpathologic discordance.
With regard to ALH, we propose surgery as first choice when at least one of these conditions are present: positive familial and mainly personal history for breast carcinoma; lesion size bigger than 1.5 em; co-presence in the bioptic sample ofhigh risk lesions; signs ofductal involvement; high histological grading for atypia. Whereas, we may propose follow-up in lesions smaller than 1.5 em, mainly if completely removed by biopsy, and without suspicious elements like a BI-RADS score of 5. Concerning LCIS, we propose surgery as first choice considering the major risk for early evolution in invasive carcinoma in respect to ALH (35) .
